In addition to weight loss benefits, GLP-1 therapy is an effective treatment for type 2 diabetes
This recommendation is also supported by the findings from the preclinical studies included in this review, which demonstrate that both GLP-1 RAs and SGLT2is work through multiple complementary mechanisms, affecting metabolic, hormonal, and inflammatory pathways in PCOS
& McGaw, L
First Drug Approved for Obesity-Related Sleep Apnea June 2024 In June 2024, the FDA approved Zepbound (tirzepatide) for treating moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity making it the first drug ever approved for this indication
The application of mTOR inhibitors mainly leads to an increase in triglycerides and leads to an increase in FFAs, which is associated with the inhibition of LPL, decreased catabolism of apolipoprotein B-100-containing lipoproteins, and excessive production of VLDL-C ( The incidence of post-transplantation diabetes mellitus (PTDM) is associated with obesity, insulin resistance and race
Alsin, the product of ALS2 gene, suppresses SOD1 mutant neurotoxicity through RhoGEF domain by interacting with SOD1 mutants
